In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s stock ...
Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.
17hOpinion
No one has ever known so much about healthy eating and been less successful at following her own advice.
Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.
Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.
At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...
In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback